Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Inv. presentation
Notes underwriting agrmnt
Cord Blood America, Inc. (CBAI)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
05/14/2018
8-K
Quarterly results
Docs:
"
Cord Blood America, Inc. Reports 2018 First Quarter Results May 14, 2018 - Cord Blood America, Inc. today announced financial results for the first quarter ended March 31, 2018. Given the agreement entered into with California Cryobank Stem Cell Services LLC to sell substantially all of the Company’s assets, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected as held-for-sale. Additional disclosure pertaining to this financial treatment is included in the Company’s 10-Q which is being filed today. Highlights Include: ● Total revenue from discontinued operations for the first quarter 2018 was $0.70 million, a decrease of 5.8% from total revenue of $0.75 million for the first quar...
"
11/13/2017
8-K
Quarterly results
Docs:
"
Cord Blood America Reports 2017 Third Quarter Results November 13, 2017 - Cord Blood America, Inc. today announced financial results for the third quarter ended September 30, 2017. Third Quarter Highlights Include: ● Total revenue for the third quarter was $0.75 million, a decrease of 3.5% from total revenue of $0.78 million for the third quarter 2016. ● Recurring storage revenue for the third quarter 2017 was $0.67 million, a decrease of 2.4% from recurring storage revenue of $0.69 million for the third quarter 2016. ● EBITDA for the third quarter 2017 was $0.24 million, an increase of 26.7% from EBITDA of $0.19 million for the third quarter 2016. Results of Operations for the Three-Months Ended September 30, 2017 For the three months ended September 30, 2017, total ...
"
08/11/2017
8-K
Quarterly results
05/15/2017
8-K
Form 8-K - Current report
03/28/2017
8-K
Form 8-K - Current report
11/14/2016
8-K
Form 8-K - Current report
08/12/2016
8-K
Form 8-K - Current report
05/16/2016
8-K
Form 8-K - Current report
03/30/2016
8-K
Quarterly results
Docs:
"
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015 March 30, 2016 - Cord Blood America, Inc. today announced financial results for the fourth quarter and fiscal year 2015. Highlights Include: ● Total revenue for the fourth quarter 2015 was $1.13 million, a decrease of 5.1% from total revenue of $1.20 million for the fourth quarter 2014. Total revenue for the year ended December 31, 2015 was $5.26 million, an increase of 21.3% from total revenue of $4.33 million for the year ended December 31, 2014. ● Recurring storage revenue for the fourth quarter 2015 was $0.65 million, an increase of 1.6% from recurring storage revenue of $0.64 million for the fourth quarter 2014. Recurring storage revenue for the year ended December 31, 2015 was $2.62 mill...
"
11/16/2015
8-K
Quarterly results
Docs:
"
Cord Blood America Reports 2015 Third Quarter Financial Results Revenue increased 19%, EBITDA of $0.33 million November 16, 2015 - Cord Blood America, Inc. today announced financial results for the third quarter ended September 30, 2015. Third Quarter Highlights Include: ● Revenue increased 19.0% to $1.43 million from $1.20 million in the same period of 2014. ● Recurring revenues increased to $0.67 million and now represents over 47% of total revenue. ● EBITDA was $0.33 million compared to $0.15 million in 2014. ● Principal debt balance was reduced by 13% during the quarter with the prepayment of $175,000. Joseph Vicente, President of Cord Blood America, Inc. commented, “Our third quarter results reflect the benefit of growth on the tissue side of our business. How...
"
11/14/2014
8-K
Quarterly results
Docs:
"
Revcenue Increased 25%, Net Income Increases by $1.13 Million to $.54 Million From Continuing Operations Cord Blood America, Inc. today announced financial results for the quarter ended September 30, 2014.
"
08/14/2014
8-K
Quarterly results
Docs:
"
US Operations Drive Recurring Revenue Growth at Over 12% LAS VEGAS, August 14, 2014 /PRNewswire/ -- Cord Blood America, Inc. today announced financial results for the quarter ended June 30, 2014. Second Quarter 2014 Highlights: ● Total revenue increased to approximately $1.54 million from $1.49 million, an increase of 3% over the same period of 2013. ● Cord Blood’s US operations saw recurring storage revenues increase by 12% and tissue related products by 20% for the comparative year over year three month period. ● Recurring revenues increased approximately 13% for the three months ended June 30, 2014 to $858,000 and now represents over 56% of total revenue. ● The Company announced on June 25, 2014, the launch of a new service offering for the isolation and expansi...
"
05/15/2014
8-K
Quarterly results
Docs:
"
Cord Blood America Announces 2014 First Quarter Financial Results Company Generated Record First Quarter Cash From Operations of $222,434 [15-May-2014] LAS VEGAS, May 15, 2014 /PRNewswire/ -- Cord Blood America, Inc. today announced financial results for the quarter ended March 31, 2014.
"
08/07/2006
8-K
Form 8-K - Current report
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy